- /
- Supported exchanges
- / US
- / BVNRY.PINK
Bavarian Nordic A/S ADR (BVNRY PINK) stock market data APIs
Bavarian Nordic A/S ADR Financial Data Overview
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bavarian Nordic A/S ADR data using free add-ons & libraries
Get Bavarian Nordic A/S ADR Fundamental Data
Bavarian Nordic A/S ADR Fundamental data includes:
- Net Revenue: 6 455 M
- EBITDA: 2 148 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bavarian Nordic A/S ADR News
New
Bavarian Nordic A/S reports Q3 results; updates FY outlook
* Bavarian Nordic A/S press release [https://www.bavarian-nordic.com/investor/news/news.aspx?news=7380] (OTCPK:BVNKF [https://seekingalpha.com/symbol/BVNKF]): Q3 Revenue of DKK 1.79B (+31.6% Y/Y). ...
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
Bavarian Nordic A/S COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business progress fo...
Bavarian Nordic Announces Changes to the Board of Directors
Bavarian Nordic A/S COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immed...
Bavarian Nordic (CPSE:BAVA): Assessing Valuation After Recent Share Price Volatility
Bavarian Nordic (CPSE:BAVA) shares have caught the attention of investors lately, as the stock has seen mixed trading activity over the past month. With price swings and a changing outlook, some are e...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.